Medetomidine and dexmedetomidine: A review of cardiovascular effects and antinociceptive properties in the dog

Veterinary Anaesthesia and Analgesia

Volumn 32, Issue 3, 2005, Pages 117-127

  Murrell, Joanna C ^a,b   Hellebrekers, Ludo J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

Antinociception; Cardiovascular; Dexmedetomidine; Dog; Medetomidine; 2 agonist

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; DEXMEDETOMIDINE; MEDETOMIDINE;

ANALGESIA; ANIMAL; ANIMAL DISEASE; CARDIOVASCULAR SYSTEM; DOG; DRUG EFFECT; PHYSIOLOGY; REVIEW;

ADRENERGIC ALPHA-AGONISTS; ANALGESIA; ANALGESICS; ANIMALS; CARDIOVASCULAR SYSTEM; DEXMEDETOMIDINE; DOGS; MEDETOMIDINE;

EID: 20844453237     PISSN: 14672987     EISSN: 14672995     Source Type: Journal    
DOI: 10.1111/j.1467-2995.2005.00233.x     Document Type: Review

References (90)

1. 2-adrenergic agonist. A review of its pharmacodynamic characteristics. Drugs Future 18, 49-91.
2. 2 adrenoreceptor mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science 215, 1394-1396.
3. Alibhai H, Clarke K, Lee Y et al. (1996) Cardiopulmonary effects of combinations of medetomidine hydrochloride and atropine sulphate in dogs. Vet Rec 138, 11-13.
4. Ansah O, Raekallio M, Vainio O (1998) Comparison of three doses of dexmedetomidine with medetomidine in cats following intramuscular administration. J Vet Pharmacol Ther 21, 380-387.
5. Ansah O, Raekallio M, Vainio O (2000) Correlation between serum concentrations following intravenous infusion of dexmedetomidine or medetomidine in cats and their sedative and analgesic effects. J Vet Pharmacol Ther 23, 1-8.
6. Arner S, Meyerson B (1988) Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33, 11-23.
7. Badoer E, Head G, Korner P (1983) Effects of intracisternal and intravenous alpha-methyldopa and clonidine on haemodynamics and baroreceptor-heart rate reflex properties in conscious rabbits. J Cardiovasc Pharmacol 5, 760-767.
8. Barnhart M, Hubbell J, Muir W (2000) Evaluation of the analgesic properties of acepromazine maleate, oxymorphone, medetomidine and a combination of acepromazine-oxymorphone. Vet Anaesth Analg 27, 89-96.
9. Bartram D, Diamond M, Tute A et al. (1994) Use of medetomidine and butorphanol for sedation in dogs. J Small Anim Pract 35, 495-498.
10. Belcher G, Ryall R, Schaffner R (1978) The differential effects of 5-hydroxytryptamine, noradrenaline and raphe stimulation on nociceptive and non-nociceptive dorsal horn interneurons in the cat. Brain Res 151, 307-321.
11. Bloor B, Frankland M, Alper G et al. (1992) Haemodynamic and sedative effects of dexmedetomidine in dog. J Pharmacol Exp Ther 263, 690-697.
12. Brodbelt D, Wood J, Young L et al. (2002) Perioperative anaesthetic complications in cats and dogs. Vet Rec 150, 616.
13. Bylund D (1985) Heterogeneity of alpha-2 adrenergic receptors. Pharmacol Biochem Behav 22, 835-843.
14. Carlton S, Honda CN, Willcockson WS et al. (1991) Descending adrenergic input to the primate spinal cord and its possible role in modulation of spinothalamic tract cells. Brain Res 591, 77-90.
15. Chilian W, Ackell P (1988) Transmural differences in sympathetic coronary constriction during exercise in the presence of coronary stenosis. Circ Res 62, 216-225.
16. Clarke K, Hall L (1990) A survey of anaesthesia in small animal practice: AVA/BSAVA report. Vet Anaesth Analg 17, 4-10.
17. Corr P, Yamada K, Witkowski F (1986) Mechanisms controlling cardiac autonomic function and their relation to arrhythmogenesis. In: The Heart and Cardiovascular System. Fozzard H, Haber E, Jennings R, Katz A, Morgan H (eds). Raven, New York, pp. 1343-1403.
18. Coughlan M, Lee JG, Bosnjak ZJ et al. (1992) Direct coronary and cerebral vascular responses to dexmedetomidine. Anaesthesiology 77, 998-1006.
19. 2-Adrenergic receptor agonist effects on supraventricular and ventricular automaticity in dogs with complete atrioventricular block. Am J Vet Res 54, 136-141.
20. Ebert TJ, Hall JE, Barney JA et al. (2000) The effects of increasing plasma concentrations of dexmedetomidine in humans. Anaesthesiology 93, 382-394.
21. Ewing KK, Mohammed HO, Scarlett J et al. (1993) Reduction of isoflurane anaesthetic requirement by medetomidine and its restoration by atipamezole in dogs. Am J Vet Res 54, 294-299.
22. 2 adrenoceptor agonists on the in vitro rat spinal cord preparation. Br J Pharmacol 124, 507-512.
23. Feigl E (1983) Coronary physiology. Physiol Rev 63, 1-205.
24. Fisher B, Zornow M, Yaksh H et al. (1991) Antinociceptive properties of intrathecal dexmedetomidine in rats. Eur J Pharmacol 192, 221-225.
25. Flacke W, Flacke J, Blow K et al. (1992) Effect of dexmedetomidine, an alpha 2 adrenergic agonist, in the isolated heart. J Cardiothorac Vasc Anesth 6, 418-423.
26. Flacke W, Flacke J, Bloor B et al. (1993) Effects of dexmedetomidine on systemic and coronary haemodynamics in the anesthetized dog. J Cardiothorac Vasc Anesth 7, 41-49.
27. Fleetwood-Walker S, Mitchell R, Hope P et al. (1985) An alpha 2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurones. Brain Res 334, 243-254.
28. Grimm K, Tranquilli W, Thurmon J et al. (2000) Duration of nonresponse to noxious stimulation after intramuscular administration of butorphanol, medetomidine, or a butorphanol-medetomidine combination during isoflurane administration in dogs. Am J Vet Res 61, 42-47.
29. Guo T, Jiang J, Buttermann A et al. (1996) Dexmedetomidine injection into the locus ceruleus produces antinociception. Anesthesiology 84, 873-881.
30. Hämäläinen M, Pertovaara A (1995) The antinociceptive action of an alpha-2-adrenoceptor agonist in the spinal dorsal horn is due to a direct spinal action and not due to activation of descending inhibition. Brain Res Bull 37, 581-587.
31. Hammond RA, England GCW (1994) The effect of medetomidine premedication upon propofol induction and infusion anaesthesia in the dog. JVAA 21, 24-28.
32. Hayashi Y, Sumikawa K, Maze M et al. (1991) Dexmedetomidine prevents epinephrine induced arrhythmias through stimulation of central alpha-2 adrenoceptors in halothane anaesthetized dogs. Anaesthesiology 75, 113-117.
33. Hellebrekers L, Sap R (1997) Medetomidine as a premedicant for ketamine, propofol or fentanyl anaesthesia in dogs. Vet Rec 140, 545-548.
34. Hellebrekers L, van Herpen H, Hird JF et al. (1998) Clinical efficacy and safety of propofol or ketamine anaesthesia in dogs premedicated with medetomidine. Vet Rec 142, 631-634.
35. Heusch G, Deussen A, Schipke J et al. (1984) Alpha-1 and alpha-2 adrenoreceptor mediated vasoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol 6, 961-968.
36. Heymann M, Payne B, Hoffman J et al. (1977) Blood flow measurements with radionuclide-labelled microspheres. Prog Cardiovasc Dis 20, 55-79.
37. Hieble J, Ruffolo R (1995) Possible structural and functional relationships between imidazoline receptors and alpha 2-adrenoreceptors. Ann N Y Acad Sci 763, 8-21.
38. Housmans P (1990) Effects of dexmedetomidine on contractility, relaxation and intracellular calcium transients of isolated ventricular myocardium. Anaesthesiology 73, 919-922.
39. Kamibayashi T, Hayashi Y, Mammoto T et al. (1995a) Role of the vagus nerve in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology 83, 992-999.
40. Kamibayashi T, Mammoto T, Hayashi Y et al. (1995b) Further characterization of the receptor mechanism involved in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology 83, 1082-1089.
41. Khan Z, Ferguson C, Jones R (1999) Alpha-2 and imidazoline receptor agonists. Anaesthesia 54, 146-165.
42. Ko J, Fox S, Mandsager R (2000) Sedative and cardiorespiratory effects of medetomidine, medetomidine-butorphanol, and medetomidine-ketamine in dogs. J Vet Med Assoc 216, 1578-1583.
43. Kuusela E, Raekallio M, Antilla M et al. (2000) Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. J Vet Pharmacol Ther 23, 15-20.
44. Kuusela E, Raekallio M, Vainio O et al. (2001) Comparison of medetomidine and dexmedetomidine as premedicants in dogs undergoing propofol-isoflurane anaesthesia. Am J Vet Res 62, 1073-1080.
45. Kuusela E, Vainio O, Short CE et al. (2003) A comparison of propofol infusion and propofol/isoflurane anaesthesia in dexmedetomidine premedicated dogs. J Vet Pharmacol Ther 26, 199-204.
46. Langer S (1981) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32, 337-362.
47. Lawrence C, Prinzen F, de Lange S (1996a) The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand. Anesth Analg 82, 544-550.
48. Lawrence C, Prinzen F, de Lange S (1996b) The effect of dexmedetomidine on nutrient organ blood flow. Anesth Analg 83, 1160-1165.
49. Lemke K, Tranquilli W, Thurmon J et al. (1992) Haemodynamic effects of atropine and glycopyrrolate in xylazine-isoflurane-anaesthetized dogs. Vet Surg 22, 163-169.
50. Link R, Desai K, Hein L et al. (1996) Cardiovascular regulation in mice lacking alpha(2)-adrenergic receptor subtypes b and c. Science 273, 803-805.
51. Lipscombe D, Kongsamt S, Tsien R (1989) Alpha adrenergic inhibition of sympathetic neurotranmsmitter release mediated by modulation of N-type calcium-channel gating. Nature 340, 639-642.
52. MacDonald E, Scheinin M (1995) Distribution and pharmacology of alpha 2 adrenoceptors in the central nervous system. J Physiol Pharmacol 46, 241-258.
53. MacDonald E, Scheinin M, Scheinin H et al. (1991) Comparison of the behavioural and neurochemical effects of the two optical enantiomers of medetomidine, a selective alpha-2-adrenoceptor agonist. J Pharmacol Exp Ther 259, 848-854.
54. Maze M, Tranquilli W (1991) Alpha-2 adrenoceptor agonists: defining the role in clinical anaesthesia. Anesthesiology 74, 581-605.
55. McQuay H (1988) Pharmacological treatment of neuralgic and neuropathic pain. Cancer Surv 7, 141-159.
56. Muir W, Werner L, Hamlin R (1975) Effects of xylazine and acetylpromazine upon induced ventricular fibrillation in dogs anaesthetized with thiamylal and halothane. Am J Vet Res 36, 1299-1303.
57. Nathan N, Feigl E (1986) Adrenergic vasoconstriction lessens transmural steal during coronary hypoperfusion. Am J Physiol 19, H645-H653.
58. Ossipov M, Harris S, LLoyd P et al. (1990) Antinociceptive interaction between opioids and medetomidine: systemic addivity and spinal synergy. Anaesthesiology 73, 1227-1235.
59. Paton W, Vizi E (1969) The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br J Pharmacol 35, 10-28.
60. Pertovaara A (1993) Antinociception induced by alpha-2-adrenoceptor agonists, with special emphasis on medetomidine studies. Prog Neurobiol 40, 691-709.
61. Pertovaara A, Kauppila A, Tukeva T (1990) The effect of medetomidine, an alpha-2-adrenoceptor agonist, in various pain tests. Eur J Pharmacol 179, 323-328.
62. Pertovaara A, Hämäläinen M, Jyvasjarvi E et al. (1991) Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in medetomidine-induced antinociception. Neuroscience 44, 705-714.
63. Pypendop B, Verstegen J (1994) A comparison of the sedative and analgesic effects of buprenorphine in combination with acepromazine, midazolam or medetomidine in dogs. Vet Anaesth Analg 21, 15-20.
64. Pypendop B, Verstegen J (1998) Haemodynamic effects of medetomidine in the dog: a dose titration study. Vet Surg 27, 612-622.
65. Pypendop B, Verstegen J (2000) Effects of a medetomidine-midazolam- butorphanol combination on renal cortical, intestinal and muscle microvascular blood flow in isoflurane anaesthetized dogs: a laser Doppler study. Vet Anaesth Analg 27, 36-44.
66. Roekaerts P, Prinzen F, de Lange S (1996a) Coronary vascular effects of dexmedetomidine during reactive hyperemia in the anaesthetized dog. J Cardiothorac Vasc Anesth 10, 619-626.
67. Roekaerts P, Prinzen F, de Lange D (1996b) Beneficial effects of dexmedetomidine on ischaemic myocardium of anaesthetized dogs. Br J Anaesth 77, 427-429.
68. 2-adrenoceptor agonist. In: Animal Pain. Short C, Poznack AV (eds). Churchill Livingstone, New York.
69. Savola J (1989) Cardiovascular actions of medetomidine and their reversal by atipamezole. Acta Anaesthesiol Scand 85, 39-47.
70. 2-adrenoreceptor agonists? Anaesthesiology 76, 873-875.
71. 2 adrenegic agonist medetomidine on systemic and coronary haemodynamics in conscious dogs. Anaesthesiology 75, 499-511.
72. Seiten E, Flacke W, Alper M (1964) Effects of calcium on isolated mammalian hearts. Am J Physiol 207, 716-720.
73. Sullivan A, Kalso E, McQuay H et al. (1992) The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in the anaesthetized rat. Eur J Pharmacol 215, 127-133.
74. Thurmon J, Ko J, Benson G et al. (1994) Hemodynamic and analgesic effects of propofol infusion in medetomidine-premedicated dogs. Am J Vet Res 55, 363-367.
75. Tibirica E, Feldman J, Mermet C et al. (1991) An imidazoline specific mechanism for the hypotensive effect of clonidine. A study with yohimbine and idazoxan. J Pharmacol Exp Ther 256, 606-613.
76. Tranquilli W, Thurman J, Benson G (1988) Alterations in epinephrine-induced arrhythmogenesis after xylazine and subsequent yohombine administration in isoflurane anaesthetized dogs. Am J Vet Res 49, 1072-1075.
77. Uhlén S, Wikberg J (1991) Rat spinal cord alpha-2-adrenoceptors are of the alpha-2A-subtype: comparison with alpha-2A- and alpha-2B- adrenoceptors in rat spleen, cerebral coretx and kidney using 3H-RX821002 ligand binding. Pharmacol Toxicol 69, 341-350.
78. Unnerstall J, Kopajtic T, Kuhar M (1984) Distribution of alpha-2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomical correlates of the pharmacological effects of clonidine and related adrenergic agents. Brain Res Brain Res Rev 7, 69-101.
79. 2 agonist, alleviates post thoracotomy pain in dogs. Lab Anim 28, 369-375.
80. Verstegen J, Fargetton X, Donnay I et al. (1990) Comaprison of the clinical utility of medetomidine/ketamine and xylazine/ketamine combinations for ovariectomy of cats. Vet Rec 127, 424-426.
81. Vickery R, Sheridan B, Segal I et al. (1988) Anesthetic and haemodynamic effects of the stereoisomers of medetomidine, an alpha 2 adrenergic agonist, in halothane anesthetized dogs. Anesth Analg 67, 611-615.
82. Wei H, Pertovaara A (1997) Peripherally administered alpha 2 adrenoceptor agonist in the modulation of chronic allodynia induced by spinal nerve ligation in the rat. Anesth Analg 85, 1122-1127.
83. Wikberg J (1979) Synthesis of 3H-acetylcholine in the rabbit lacrimal gland and its release by electrical field stimulation. Acta Physiol Scand 468 (Suppl.), 1-89.
84. Williams JT, Henderson G, North RA (1985) Characterization of alpha 2-adrenoreceptors which increase potassium conductance in rat locus coeruleus neurones. Neuroscience 14, 95-101.
85. Woodman O, Vatner S (1986) Cardiovascular responses to the stimulation of alpha 1 and alpha 2 -adrenoreceptors in the conscious dog. J Pharmacol Exp Ther 237, 86-91.
86. Xu M, Wei H, Kontinen K et al. (2000) The dissociation of sedative from spinal antinociceptive effects following adminsitration of a novel alpha-2-adrenoceptor agonist, MPV-2426, in the locus coeruleus in the rat. Acta Anaesthesiol Scand 44, 648-655.
87. Yaksh T (1985) Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 22, 845-858.
88. Yaksh T, Pogrel J, Lee YW et al. (1995) Reversal of nerve-ligation induced allodynia by spinal alpha 2 adrenoceptor agonists. J Pharmacol Exp Ther 272, 207-214.
89. Young L, Brearley J, Richards D et al. (1990) Medetomidine as a premedicant in dogs and its reversal by atipamezole. J Small Anim Pract 31, 554-559.
90. Zanderberg P, Timmermans P, Zwieten PV (1984) Hemodynamic profiles of methohexamine and B-HT 933 in spinalized ganglion blocked dogs. J Cardiovasc Pharmacol 6, 256-262.